Melvin R. Echols, MD, FACC, FHFSA, FASPC (@melvinechols9) 's Twitter Profile
Melvin R. Echols, MD, FACC, FHFSA, FASPC

@melvinechols9

Chief DEI Officer for ACC, Fellowship PD, Morehouse School of Medicine. Gen-HF Cardiologist, Equity & HF Researcher. Ed. Brd.. #JACC, #SoMe, #JACCHF, @JCardFail

ID: 1220552971274072064

calendar_today24-01-2020 03:44:49

1,1K Tweet

2,2K Followers

357 Following

Dr. Purvi Parwani (@purviparwani) 's Twitter Profile Photo

#ESCcongress #AF guidelines What’s new?➡️ 🆕 importance of optimal care according to the new AF-CARE pathway, C] Comorbidity and risk factor management; A] Avoid stroke and thromboembolism; R] Reduce symptoms by rate and rhythm control; E] Evaluation and dynamic

#ESCcongress 
#AF guidelines 
What’s new?➡️

🆕 importance of optimal care according to the new AF-CARE pathway, 

C] Comorbidity and risk factor management;
A] Avoid stroke and thromboembolism;
R] Reduce symptoms by rate and rhythm control; 
 E] Evaluation and dynamic
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Chronic coronary syndromes: diagnosis, management and gaps in evidence⤵️ #2024Review #OpenAccess 🔹hvt-journal.com/articles/art508 #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter

🔴Chronic coronary syndromes: diagnosis, management and gaps in evidence⤵️ #2024Review #OpenAccess

🔹hvt-journal.com/articles/art508
 #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

Meta-analysis of all trials related to timing of treatment agree that time of meds just doesn’t matter! #ESCCongress #ESCHotline #cvPrev #HTN 📍 no difference in all-cause mortality for evening and morning dosing (HR 0.77; 95% CI 0.51–1.16)

Meta-analysis of all trials related to timing of treatment agree that time of meds just doesn’t matter! 
#ESCCongress #ESCHotline #cvPrev #HTN 
📍 no difference in all-cause mortality for evening and morning dosing (HR 0.77; 95% CI 0.51–1.16)
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴BASIC CARDIAC RHYTHMS DECISION TREE ⤵️🔹 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicineball

🔴BASIC CARDIAC RHYTHMS DECISION TREE ⤵️🔹

 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicineball
JACC Journals (@jaccjournals) 's Twitter Profile Photo

New 👀insights from the International #Takotsubo (InterTAK) registry! ⬆️ prevalence in ♂️, ⬆️ recognition of midventricular TTS type, & ⬆️ short-term mortality & rates of 🫀 shock in recent years bit.ly/3Xjd7jE #ESCCongress #JACC

New 👀insights from the International #Takotsubo (InterTAK) registry!

⬆️ prevalence in ♂️, ⬆️ recognition of midventricular TTS type, & ⬆️ short-term mortality & rates of 🫀 shock in recent years bit.ly/3Xjd7jE

#ESCCongress #JACC
Harriette Van Spall, MD MPH (@hvanspall) 's Twitter Profile Photo

#FineArtsHF RCT 7463 pts with HF and EF of at least 40% (Mean LVEF 53%) #Fineronone, a nsMRA: ⬇️ the primary composite CV death & HF events by 16%, largely driven ⬇️ HF events Results consistent across subgroups Lower hypoK Higher hyperK #ESCCongress

#FineArtsHF RCT

7463 pts with HF and EF of at least 40%
(Mean LVEF 53%)

#Fineronone, a nsMRA: 

⬇️ the primary composite CV death & HF events by 16%, largely driven ⬇️ HF events

Results consistent across subgroups

Lower hypoK
Higher hyperK

#ESCCongress
Henry Han (@hancardiomd) 's Twitter Profile Photo

#MRAs in heart failure: an individual patient level meta-analysis 👥13,846 patients analyzed across 4 major HF trials ; #RALES (spironolactone) #EMPHASIS-HF (eplerenone) #TOPCAT (spironolactone) #FINEARTS-HF (finerenone) 📍MRAs ⬇️ risk of CV death or HF hospitalization by

#MRAs in heart failure: an individual patient level meta-analysis

👥13,846 patients analyzed across 4 major HF trials ;

#RALES (spironolactone)
#EMPHASIS-HF (eplerenone) 
#TOPCAT (spironolactone)
#FINEARTS-HF (finerenone) 

📍MRAs ⬇️ risk of CV death or HF hospitalization by
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴STEMI without ST elevations ❤️⤵️ 🔹The Little ECG book by Dr. Ahmed Atta Hard points became easier ❤️ #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical

🔴STEMI without ST elevations ❤️⤵️

🔹The Little ECG book by Dr. Ahmed Atta 

Hard points became easier ❤️
 #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter #medical
Andrew J Sauer MD (@andrewjsauer) 's Twitter Profile Photo

🔥 fresh SoA review 🔥 JACC Journals To supplement discussion of #MRA European Society of Cardiology News European Society of Cardiology We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.

🔥 fresh SoA review 🔥 <a href="/JACCJournals/">JACC Journals</a> 

To supplement discussion of #MRA

<a href="/ESCardioNews/">European Society of Cardiology News</a> <a href="/escardio/">European Society of Cardiology</a> 

We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

🚨FINEARTS-HF trial, finerenone reduced HF events and cardiovascular death in patients with HFmrEF/HFpEF🚨 #ESCCongress #FINEARTS #HFpEF #LBCT #ESCHotline 📎 nejm.org/doi/abs/10.105… 📍46%💃🏻 📍16% Asian 📍mean age 72y 📍not on top of SGLT2i 📍v symptomatic population

🚨FINEARTS-HF trial, finerenone reduced HF events and cardiovascular death in patients with HFmrEF/HFpEF🚨
#ESCCongress #FINEARTS #HFpEF #LBCT #ESCHotline 
📎 nejm.org/doi/abs/10.105…

📍46%💃🏻
📍16% Asian
📍mean age 72y
📍not on top of SGLT2i
📍v symptomatic population
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Mineralocorticoid Antagonism in Heart Failure: Established & Emerging Therapeutic Role ⤵️State-Of-The-Art #2024Review JACC Journals 🔹jacc.org/doi/10.1016/j.… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter

🔴Mineralocorticoid Antagonism in Heart Failure: Established &amp; Emerging Therapeutic Role ⤵️State-Of-The-Art  #2024Review  <a href="/JACCJournals/">JACC Journals</a>

🔹jacc.org/doi/10.1016/j.… 
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Proposed HFpEF Treatment Algorithm⤵️ 🔹After #FINEARTSHF results released at #ESCCongress ❇️FINEARTS-HF met its primary endpoint: ⬇️ 16% CV death & total HF events and also improved health status KCCW-TSS 🔹nejm.org/doi/full/10.10… #Cardiology #FOAMed #MedEd #medstudent

🔴Proposed HFpEF Treatment Algorithm⤵️

🔹After #FINEARTSHF results released at #ESCCongress  
❇️FINEARTS-HF met its primary endpoint: 
⬇️ 16% CV death &amp; total HF events  and also improved health status KCCW-TSS

🔹nejm.org/doi/full/10.10…
 #Cardiology #FOAMed #MedEd #medstudent
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications ⬇️ #ESCCongress 🔹 bit.ly/3AJSR23 #medtwitterWhat #MedTwitter #CardioEd #CVT #medx #medEd #CardioTwitter #cardiotwitter

🔴CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications ⬇️ #ESCCongress
 
🔹 bit.ly/3AJSR23
 #medtwitterWhat #MedTwitter #CardioEd #CVT #medx #medEd #CardioTwitter #cardiotwitter
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

From JAMA: In patients with symptomatic atrial fibrillation (AF), pulmonary vein isolation resulted in a significant & clinically important decrease in AF burden, with substantial improvements in symptoms and QoL, vs a sham procedure. ja.ma/3z0AFR1 #ESCCongress

From <a href="/JAMA_current/">JAMA</a>: In patients with symptomatic atrial fibrillation (AF), pulmonary vein isolation resulted in a significant &amp; clinically important decrease in AF burden, with substantial improvements in symptoms and QoL, vs a sham procedure. ja.ma/3z0AFR1 #ESCCongress
JACC Journals (@jaccjournals) 's Twitter Profile Photo

In the COMBINE-AF study, #biomarkers NTproBNP, hs-cTnT & GDF-15 improve #heartfailure risk assessment in #Afib! hs-cTnT is equally important as #NTproBNP for HF risk assessment bit.ly/3ySKhNR #ESCCongress #JACC Paul M Haller Robert Giugliano TIMI Study Group

In the COMBINE-AF study, #biomarkers NTproBNP, hs-cTnT &amp; GDF-15 improve #heartfailure risk assessment in #Afib!

hs-cTnT is equally important as #NTproBNP for HF risk assessment bit.ly/3ySKhNR

#ESCCongress #JACC <a href="/PaulMHaller/">Paul M Haller</a> <a href="/rgiugliano/">Robert Giugliano</a> <a href="/TIMIStudyGroup/">TIMI Study Group</a>
Rachel M Bond, MD (@drrachelmbond) 's Twitter Profile Photo

Hypertension is a leading risk factor for 🫀 disease, and despite comprehensive guidelines, we’re seeing an alarming ⬆️ in hypertension among non-Hispanic Black women, often at earlier stages in their lives. ✅out 👇🏽 cc: uché blackstock, md Association of Black Cardiologists Sharonne Hayes MD ABGH

Hypertension is a leading risk factor for 🫀 disease, and despite comprehensive guidelines, we’re seeing an alarming ⬆️ in hypertension among non-Hispanic Black women, often at earlier stages in their lives. ✅out 👇🏽 cc: <a href="/uche_blackstock/">uché blackstock, md</a> <a href="/ABCardio1/">Association of Black Cardiologists</a> <a href="/SharonneHayes/">Sharonne Hayes MD</a> <a href="/blackingastro/">ABGH</a>
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Aortic Regurgitation: from mechanisms to management ⤵️STATE-OF-THE-ART #2024Review 🔹eurointervention.pcronline.com/article/aortic… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular

🔴Aortic Regurgitation: from mechanisms to management ⤵️STATE-OF-THE-ART #2024Review  

🔹eurointervention.pcronline.com/article/aortic…
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴 Digoxin Intoxication: Rapid Review ❤️🩺⤵️ 🔹recapem.com/digoxin-intoxi… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicine

🔴 Digoxin Intoxication: Rapid Review ❤️🩺⤵️

🔹recapem.com/digoxin-intoxi…
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicine
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Proximal versus distal diuretics in congestive HF ⤵️ #2024Review #OpenAccess 🔹academic.oup.com/ndt/article/39… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

🔴Proximal versus distal diuretics in congestive HF ⤵️ #2024Review #OpenAccess

🔹academic.oup.com/ndt/article/39…
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular #MedTwitter #medical #medEd